In one study, METTL1 overexpression increased the lethal impact of cisplatin via the S100A4/p53 pathway on cisplatin-resistant colon cancer cells.50 Another study discovered that METTL1 is frequently amplified and over expressed in malignancies, which is linked to poor patient survival. This evidence concerns the gene TP53 and malignant colon neoplasm.